Search research articles
Contact Us
Filters
Showing results (331-340 of 380) with videos related to
Page
of 38
Sort By:
Diagnostic Pathology
|
August 23, 2011
Subtype distribution of lymphomas in Southwest China: analysis of 6,382 cases using WHO classification in a single institution
Qun-Pei Yang, Wen-Yan Zhang, Jian-Bo Yu, et al.
Scientific Reports
|
December 20, 2016
Efficacy and safety of thrombopoietin receptor agonists in patients with primary immune thrombocytopenia: A systematic review and meta-analysis
Li Wang, Zhe Gao, Xiao-Ping Chen, et al.
BMC Cancer
|
February 19, 2022
The genetic landscape of pancreatic head ductal adenocarcinoma in China and prognosis stratification
Yefan Yang, Ying Ding, Yuxi Gong, et al.
Genomics
|
March 11, 2021
Aberrant methylation modifications reflect specific drug responses in small cell lung cancer
Peixin Chen, Haoyue Guo, Yu Liu, et al.
British Journal of Cancer
|
May 3, 2018
Chemerin suppresses hepatocellular carcinoma metastasis through CMKLR1-PTEN-Akt axis
Jing-Jing Li, Hong-Kun Yin, Dong-Xian Guan, et al.
Signal Transduction and Targeted Therapy
|
November 10, 2025
Ablation plus immunotherapy versus immunotherapy alone in patients of advanced NSCLC who develop oligo-residual disease after anti-PD-1/L1 therapy (BOOSTER): a randomized phase 2 trial
Shuo Yang, Xinyu Liu, Jia Yu, et al.
Medrxiv : the Preprint Server for Health Sciences
|
December 23, 2024
A Unified Flexible Large Polysomnography Model for Sleep Staging and Mental Disorder Diagnosis
Guifeng Deng, Mengfan Niu, Shuying Rao, et al.
Cancer Medicine
|
December 4, 2015
Five-year analysis from phase 2 trial of "sandwich" chemoradiotherapy in newly diagnosed, stage IE to IIE, nasal type, extranodal natural killer/T-cell lymphoma
Li Zhang, Ming Jiang, Li Xie, et al.
Journal of Cellular and Molecular Medicine
|
January 3, 2020
Exosomes transmit T790M mutation-induced resistance in EGFR-mutant NSCLC by activating PI3K/AKT signalling pathway
Xiaozhen Liu, Tao Jiang, Xuefei Li, et al.
Nature Communications
|
February 9, 2012
EphB3 suppresses non-small-cell lung cancer metastasis via a PP2A/RACK1/Akt signalling complex
Guo Li, Xiao-Dan Ji, Hong Gao, et al.
Page
of 38
Search research articles
Search
Showing results (331-340 of 380) with videos related to
Sort By:
Page
of 38
Diagnostic Pathology
|
August 23, 2011
Subtype distribution of lymphomas in Southwest China: analysis of 6,382 cases using WHO classification in a single institution
Qun-Pei Yang, Wen-Yan Zhang, Jian-Bo Yu, et al.
Scientific Reports
|
December 20, 2016
Efficacy and safety of thrombopoietin receptor agonists in patients with primary immune thrombocytopenia: A systematic review and meta-analysis
Li Wang, Zhe Gao, Xiao-Ping Chen, et al.
BMC Cancer
|
February 19, 2022
The genetic landscape of pancreatic head ductal adenocarcinoma in China and prognosis stratification
Yefan Yang, Ying Ding, Yuxi Gong, et al.
Genomics
|
March 11, 2021
Aberrant methylation modifications reflect specific drug responses in small cell lung cancer
Peixin Chen, Haoyue Guo, Yu Liu, et al.
British Journal of Cancer
|
May 3, 2018
Chemerin suppresses hepatocellular carcinoma metastasis through CMKLR1-PTEN-Akt axis
Jing-Jing Li, Hong-Kun Yin, Dong-Xian Guan, et al.
Signal Transduction and Targeted Therapy
|
November 10, 2025
Ablation plus immunotherapy versus immunotherapy alone in patients of advanced NSCLC who develop oligo-residual disease after anti-PD-1/L1 therapy (BOOSTER): a randomized phase 2 trial
Shuo Yang, Xinyu Liu, Jia Yu, et al.
Medrxiv : the Preprint Server for Health Sciences
|
December 23, 2024
A Unified Flexible Large Polysomnography Model for Sleep Staging and Mental Disorder Diagnosis
Guifeng Deng, Mengfan Niu, Shuying Rao, et al.
Cancer Medicine
|
December 4, 2015
Five-year analysis from phase 2 trial of "sandwich" chemoradiotherapy in newly diagnosed, stage IE to IIE, nasal type, extranodal natural killer/T-cell lymphoma
Li Zhang, Ming Jiang, Li Xie, et al.
Journal of Cellular and Molecular Medicine
|
January 3, 2020
Exosomes transmit T790M mutation-induced resistance in EGFR-mutant NSCLC by activating PI3K/AKT signalling pathway
Xiaozhen Liu, Tao Jiang, Xuefei Li, et al.
Nature Communications
|
February 9, 2012
EphB3 suppresses non-small-cell lung cancer metastasis via a PP2A/RACK1/Akt signalling complex
Guo Li, Xiao-Dan Ji, Hong Gao, et al.
Page
of 38